Bioequivalence of lovastatin capsules in healthy volunteers
Dan Liu
Abstract
Dan Liu
Abstract
Objective: To evaluate the bioequivalence of two different lovastatin capsules in healthy volunteers.Methods:The whole blood concentrations of lovastatin in 20 male healthy volunteers taking orally tested and reference preparations after a single dose were determined by LC/MS/MS.The pharmacokinetic parameters were calculated by DAS2.1 software.Results:The main pharmacokinetic parameters of two lovastatin capsules were as follows:t1/2 were(4.67±2.34) and(5.30±2.62) h;tmax were(1.90±0.50) and(2.13±0.39) h;Cmax were(8.37±0.84) and(8.29±1.00) ng·mL-1;AUC0-t were(32.25±6.49)and(32.71±7.59) ng·h·mL-1;AUC0-∞ were(33.62±6.94) and(34.71±8.62) ng·h·mL-1.The relative bioavailability of test preparation was(99.60±8.30)%.Conclusion:The tested preparation was bioequivalent to the reference preparation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To evaluate the bioequivalence of two different lovastatin capsules in healthy volunteers.Methods:The whole blood concentrations of lovastatin in 20 male healthy volunteers taking orally tested and reference preparations after a single dose were determined by LC/MS/MS.The pharmacokinetic parameters were calculated by DAS2.1 software.Results:The main pharmacokinetic parameters of two lovastatin capsules were as follows:t1/2 were(4.67±2.34) and(5.30±2.62) h;tmax were(1.90±0.50) and(2.13±0.39) h;Cmax were(8.37±0.84) and(8.29±1.00) ng·mL-1;AUC0-t were(32.25±6.49)and(32.71±7.59) ng·h·mL-1;AUC0-∞ were(33.62±6.94) and(34.71±8.62) ng·h·mL-1.The relative bioavailability of test preparation was(99.60±8.30)%.Conclusion:The tested preparation was bioequivalent to the reference preparation.
Key concepts: Bioequivalence, Lovastatin, Medicine, Cmax, Pharmacokinetics, Bioavailability, Pharmacology, Internal medicine